Large-scale testing (Phase 3)Study completedNCT03881696
What this trial is testing
Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants
Who this might be right for
Peanut AllergyMulti-food Allergy
National Institute of Allergy and Infectious Diseases (NIAID) 458